ReviewESMO open2019

New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5).

Manuel Piechutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.